VJHemOnc is committed to improving our service to you

ISAL 2019 | Histamine dihydrochloride and IL-2 for AML: impacts for relapse risk and survival

VJHemOnc is committed to improving our service to you

Anna Martner

Anna Martner, PhD, of the University of Gothenburg, Gothenburg, Sweden, discusses the mechanism of action of the combination of histamine dihydrochloride and IL-2, and its impacts for relapse risk and survival in acute myeloid leukemia (AML). This interview was held at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter